Geovax Labs (GOVX)

$0.72 -0.01 (-1.31%)
Market Cap 10.99M
Revenue (ttm) 3.95M
Net Income (ttm) -24.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -632.66%
Debt to Equity Ratio 0.00
Volume 956,079
Avg Vol 1,593,984
Day's Range N/A - N/A
Shares Out 15.93M
Stochastic %K 90%
Beta 3.36
Analysts Strong Sell
Price Target $10.38

Company Profile

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tu...

Industry: Biotechnology
Sector: Healthcare
Phone: (678) 384-7220
Fax: (678) 384-7281
Address:
1900 Lake Park Drive, Suite 380, Smyrna, United States
Invest2live
Invest2live Jul. 17 at 5:51 PM
$GOVX excellent value; do your DD and get in.
0 · Reply
lealbinagor98
lealbinagor98 Jul. 17 at 2:25 PM
$SRPT excellent moment, be patience ⏰️🚀🔥😎 $NVAX $GOVX $CHRS
0 · Reply
RT234
RT234 Jul. 17 at 1:12 PM
$GOVX cool
0 · Reply
JarvisFlow
JarvisFlow Jul. 17 at 1:00 PM
D. Boral Capital has updated their rating for Geovax Labs ( $GOVX ) to Buy with a price target of 9.
0 · Reply
ChasingtheLambo
ChasingtheLambo Jul. 17 at 12:03 PM
$GOVX Yesssss sir!!!!!
0 · Reply
ChasingtheLambo
ChasingtheLambo Jul. 17 at 12:03 PM
$GOVX Do they announce closing of the offering today? All signs say yes!!!! Come on small caps taking the lead but all analysts say buy!!!!!!!! Nothing has changed here
0 · Reply
BuckSlayer
BuckSlayer Jul. 16 at 7:38 PM
$GOVX Up 73% 🧐
0 · Reply
TraderUKBoyy
TraderUKBoyy Jul. 16 at 7:35 PM
$GOVX More red candles !! Would have been nice if it closed above 0.76.. but it’s GOVX managed by crooked oldie gang !!
0 · Reply
ChasingtheLambo
ChasingtheLambo Jul. 16 at 7:21 PM
$GOVX Come on .7561
0 · Reply
juvie22
juvie22 Jul. 16 at 7:05 PM
$GOVX
0 · Reply
Latest News on GOVX
GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

May 1, 2025, 8:58 PM EDT - 2 months ago

GeoVax Labs, Inc. (GOVX) Q1 2025 Earnings Call Transcript

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 8:53 PM EDT - 3 months ago

GeoVax Labs, Inc. (GOVX) Q4 2024 Earnings Call Transcript

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Dec 9, 2024, 9:00 AM EST - 7 months ago

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

Nov 26, 2024, 9:00 AM EST - 8 months ago

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 11:33 PM EST - 8 months ago

GeoVax Labs, Inc. (GOVX) Q3 2024 Earnings Call Transcript

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 12, 2024, 4:00 PM EST - 8 months ago

GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

Nov 5, 2024, 9:00 AM EST - 9 months ago

GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 2, 2024, 9:00 AM EDT - 10 months ago

GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

GeoVax to Participate in Upcoming Investor Conferences in September

Sep 3, 2024, 9:00 AM EDT - 11 months ago

GeoVax to Participate in Upcoming Investor Conferences in September

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

Aug 28, 2024, 8:59 PM EDT - 11 months ago

GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

Aug 20, 2024, 8:09 AM EDT - 11 months ago

GeoVax's stock slides 20% after company raises $8.5 million in stock sale

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Aug 20, 2024, 7:45 AM EDT - 11 months ago

GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 11 months ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GDTC GOSS IMRN

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

Aug 19, 2024, 7:30 AM EDT - 11 months ago

GeoVax's stock soars 54% to lead rally in companies developing mpox treatments

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Aug 15, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the Emerging Growth Conference on August 21, 2024

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

Aug 15, 2024, 8:36 AM EDT - 1 year ago

Mpox outbreak: 5 stocks to watch out for as the emergency unfolds

EBS SIGA

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 6:15 AM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q2 2024 Earnings Call Transcript

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

Aug 8, 2024, 9:00 AM EDT - 1 year ago

GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 6, 2024, 4:00 PM EDT - 1 year ago

GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

Jul 31, 2024, 10:15 AM EDT - 1 year ago

Update: GeoVax Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

May 14, 2024, 8:01 PM EDT - 1 year ago

GeoVax Labs, Inc. (GOVX) Q1 2024 Earnings Call Transcript

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

Apr 4, 2024, 12:30 PM EDT - 1 year ago

GeoVax Presents Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

Mar 28, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress

GeoVax to Present at the 36th Annual Roth Conference

Mar 12, 2024, 9:00 AM EDT - 1 year ago

GeoVax to Present at the 36th Annual Roth Conference

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

Mar 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

Mar 1, 2024, 2:34 AM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q4 2023 Earnings Call Transcript

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

Feb 29, 2024, 4:00 PM EST - 1 year ago

GeoVax Reports 2023 Year-End Financial Results and Provides Business Update

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

Feb 22, 2024, 9:00 AM EST - 1 year ago

GeoVax to Report 2023 Financial Results and Provide Corporate Update on February 29, 2024

GeoVax to Present at the 2024 BIO CEO & Investor Conference

Feb 19, 2024, 9:00 AM EST - 1 year ago

GeoVax to Present at the 2024 BIO CEO & Investor Conference

GeoVax Announces Multiple Patent Issuances and Allowances

Feb 13, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Multiple Patent Issuances and Allowances

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

Feb 6, 2024, 9:00 AM EST - 1 year ago

GeoVax Reports Positive Interim Data From Phase 2 Clinical Trial of GEO-CM04S1 as a Universal Covid-19 Vaccine Booster

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

Jan 29, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces 1-for-15 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

Jan 8, 2024, 9:00 AM EST - 1 year ago

GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

Jan 4, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Gedeptin® Patient Enrollment Closure for Phase 1/2 Clinical Trial Among Advanced Head and Neck Cancer Patients

GeoVax Announces Issuance of Malaria Vaccine Patent

Jan 3, 2024, 9:00 AM EST - 1 year ago

GeoVax Announces Issuance of Malaria Vaccine Patent

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

Dec 27, 2023, 9:00 AM EST - 1 year ago

GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2024

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

Dec 19, 2023, 9:00 AM EST - 1 year ago

GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

Nov 30, 2023, 4:30 PM EST - 1 year ago

GeoVax Hemorrhagic Fever Vaccine Data Presented at World Vaccine Congress

GeoVax to Participate in Upcoming December Investor Events

Nov 29, 2023, 9:00 AM EST - 1 year ago

GeoVax to Participate in Upcoming December Investor Events

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Nov 28, 2023, 9:00 AM EST - 1 year ago

GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

Nov 14, 2023, 9:00 AM EST - 1 year ago

Progress on GeoVax's Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 9:26 PM EST - 1 year ago

GeoVax Labs, Inc. (GOVX) Q3 2023 Earnings Call Transcript

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 8, 2023, 4:00 PM EST - 1 year ago

GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

Oct 30, 2023, 9:00 AM EDT - 1 year ago

GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine

GeoVax to Participate in Upcoming November Investor and Industry Events

Oct 25, 2023, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming November Investor and Industry Events

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

Oct 24, 2023, 9:00 AM EDT - 1 year ago

GeoVax Update: Clinical and Operational Progress Toward Transformative Opportunities

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

Oct 9, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for Marburg Vaccine Patent

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

Oct 5, 2023, 9:00 AM EDT - 1 year ago

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

GeoVax to Participate in Upcoming October Investor and Industry Events

Sep 27, 2023, 9:00 AM EDT - 1 year ago

GeoVax to Participate in Upcoming October Investor and Industry Events

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference

Sep 20, 2023, 9:00 AM EDT - 1 year ago

GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference

Invest2live
Invest2live Jul. 17 at 5:51 PM
$GOVX excellent value; do your DD and get in.
0 · Reply
lealbinagor98
lealbinagor98 Jul. 17 at 2:25 PM
$SRPT excellent moment, be patience ⏰️🚀🔥😎 $NVAX $GOVX $CHRS
0 · Reply
RT234
RT234 Jul. 17 at 1:12 PM
$GOVX cool
0 · Reply
JarvisFlow
JarvisFlow Jul. 17 at 1:00 PM
D. Boral Capital has updated their rating for Geovax Labs ( $GOVX ) to Buy with a price target of 9.
0 · Reply
ChasingtheLambo
ChasingtheLambo Jul. 17 at 12:03 PM
$GOVX Yesssss sir!!!!!
0 · Reply
ChasingtheLambo
ChasingtheLambo Jul. 17 at 12:03 PM
$GOVX Do they announce closing of the offering today? All signs say yes!!!! Come on small caps taking the lead but all analysts say buy!!!!!!!! Nothing has changed here
0 · Reply
BuckSlayer
BuckSlayer Jul. 16 at 7:38 PM
$GOVX Up 73% 🧐
0 · Reply
TraderUKBoyy
TraderUKBoyy Jul. 16 at 7:35 PM
$GOVX More red candles !! Would have been nice if it closed above 0.76.. but it’s GOVX managed by crooked oldie gang !!
0 · Reply
ChasingtheLambo
ChasingtheLambo Jul. 16 at 7:21 PM
$GOVX Come on .7561
0 · Reply
juvie22
juvie22 Jul. 16 at 7:05 PM
$GOVX
0 · Reply
ChasingtheLambo
ChasingtheLambo Jul. 16 at 6:48 PM
$GOVX .7561 sets this free
0 · Reply
geniuscali
geniuscali Jul. 16 at 6:14 PM
$GOVX lol listen starting at 24:10 He tells you buckle up for even more dilution coming!!!!!!!!
0 · Reply
KittyStonkEnterprises
KittyStonkEnterprises Jul. 16 at 5:59 PM
$GOVX To The Moon
0 · Reply
TraderUKBoyy
TraderUKBoyy Jul. 16 at 5:58 PM
$GOVX Today’s presentation.. Watch last few minutes when they talk about Reverse stock split possibilities https://youtu.be/XW1thqDKO_E?feature=shared
0 · Reply
TraderUKBoyy
TraderUKBoyy Jul. 16 at 5:41 PM
$GOVX Big red candle.. Looks like party over now with presentation just completed by Dodd ..
0 · Reply
MrMaxxxx
MrMaxxxx Jul. 16 at 5:36 PM
$GOVX Me like
0 · Reply
TraderUKBoyy
TraderUKBoyy Jul. 16 at 5:31 PM
$GOVX. Hits $0.76 🎯🎯🎯
0 · Reply
To_De_Moon
To_De_Moon Jul. 16 at 5:30 PM
$GOVX
1 · Reply
daytraderaibna
daytraderaibna Jul. 16 at 5:13 PM
$GOVX Now, our next resistance is $0.76. If we are able to take that huge red candle down, oh boy, it will catapult us to $1 and beyond at no time as shorts will be covering big time. Look at the volume of that candle! almost 11mln! Hit the like if you agree with me!
2 · Reply
Manjanja
Manjanja Jul. 16 at 4:58 PM
$GOVX if this hits 1$ I can finally buy my dream car a Prius 💪🏼
1 · Reply
VitaminX
VitaminX Jul. 16 at 4:58 PM
$GOVX
0 · Reply
daytraderaibna
daytraderaibna Jul. 16 at 3:17 PM
$GOVX
0 · Reply